BSX vs CIMO
Boston Scientific Corp (BSX) versus Chimera Investment Corporation (CIMO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Chimera Investment Corporation (CIMO) common stock listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
CIMO does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CIMO currently screens at market cap $0.
Not investment advice. Open the BSX and CIMO stock pages for the full models.
Not investment advice.